Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples
出版年份 2020 全文链接
标题
Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples
作者
关键词
-
出版物
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 39, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-05-27
DOI
10.1186/s13046-020-01601-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer
- (2019) Gillian Vandekerkhove et al. EUROPEAN UROLOGY
- Serum LincRNA-p21 Expression in Primary Liver Diseases and Liver Metastatic Diseases
- (2019) Shun Wang et al. PATHOLOGY RESEARCH AND PRACTICE
- Circulating miRNAs as a marker of metastatic disease and prognostic factor in metastatic breast cancer
- (2019) Chara Papadaki et al. Oncotarget
- T cell receptor β-chain repertoire analysis to reveal potential predictive biomarker for the use of immune checkpoint blockade in patients with advanced solid tumors.
- (2019) Ye Li et al. JOURNAL OF CLINICAL ONCOLOGY
- A novel noninvasive biomarker based on peripheral PD-1posi CD8 T-cell receptor repertoire correlated with clinical outcomes to immunotherapy in non-small cell lung cancer.
- (2019) Jie-Fei Han et al. JOURNAL OF CLINICAL ONCOLOGY
- Correlation between peripheral CD8+PD-1+ T cells diversity, tumor mutation burden (TMB) and T cell clones with anti-PD-1 antibody treatment of lung cancer patients: TCR repertoire as a novel predictive biomarker.
- (2019) Seiji Matsumoto et al. JOURNAL OF CLINICAL ONCOLOGY
- Intratumoral Heterogeneity: More Than Just Mutations
- (2019) Kunihiko Hinohara et al. TRENDS IN CELL BIOLOGY
- Immunogenic cell death in cancer therapy: Present and emerging inducers
- (2019) Jingyi Zhou et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance
- (2019) Vivek Verma et al. NATURE IMMUNOLOGY
- Clonality of CD4+ Blood T Cells Predicts Longer Survival With CTLA4 or PD-1 Checkpoint Inhibition in Advanced Melanoma
- (2019) Akiko Arakawa et al. Frontiers in Immunology
- Circulating Tumor Cells in Right- and Left-Sided Colorectal Cancer
- (2019) Chiara Nicolazzo et al. Cancers
- Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade
- (2019) Jonas Bochem et al. PLoS One
- Blood Immune Cell Biomarkers in Patient With Lung Cancer Undergoing Treatment With Checkpoint Blockade
- (2019) Miriam Möller et al. JOURNAL OF IMMUNOTHERAPY
- Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer
- (2019) Kroopa Joshi et al. NATURE MEDICINE
- Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle
- (2018) L De Mattos-Arruda et al. ANNALS OF ONCOLOGY
- Non-conventional Inhibitory CD4 + Foxp3 − PD-1 hi T Cells as a Biomarker of Immune Checkpoint Blockade Activity
- (2018) Roberta Zappasodi et al. CANCER CELL
- Exosomal lncRNA 91H is associated with poor development in colorectal cancer by modifying HNRNPK expression
- (2018) Tianyi Gao et al. Cancer Cell International
- HOTAIR: An Oncogenic Long Non-Coding RNA in Human Cancer
- (2018) Qing Tang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Dynamics of EGFR Mutation Load in Plasma for Prediction of Treatment Response and Disease Progression in Patients With EGFR -Mutant Lung Adenocarcinoma
- (2018) Álvaro Taus et al. Clinical Lung Cancer
- Mass cytometry: a powerful tool for dissecting the immune landscape
- (2018) Yannick Simoni et al. CURRENT OPINION IN IMMUNOLOGY
- Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer
- (2018) Daniel G. Stover et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
- (2018) Jason D. Merker et al. JOURNAL OF CLINICAL ONCOLOGY
- PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab
- (2018) Nicolas Guibert et al. LUNG CANCER
- High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy
- (2018) Carsten Krieg et al. NATURE MEDICINE
- Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer
- (2018) Ben O’Leary et al. Nature Communications
- Increased diversity with reduced “diversity evenness” of tumor infiltrating T-cells for the successful cancer immunotherapy
- (2018) Akihiro Hosoi et al. Scientific Reports
- Identification of Tumoricidal TCRs from Tumor-Infiltrating Lymphocytes by Single-Cell Analysis
- (2018) Kiyomi Shitaoka et al. Cancer Immunology Research
- Distinct predictive biomarker candidates for response to anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients
- (2018) Priyanka B. Subrahmanyam et al. Journal for ImmunoTherapy of Cancer
- Circ-ZEB1.33 promotes the proliferation of human HCC by sponging miR-200a-3p and upregulating CDK6
- (2018) Yuhua Gong et al. Cancer Cell International
- The roles of tumor-derived exosomes in non-small cell lung cancer and their clinical implications
- (2018) Hongmei Zheng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Emerging function and potential diagnostic value of circular RNAs in cancer
- (2018) Xianglun Cui et al. Molecular Cancer
- Circulating Tumor Cells
- (2018) Kaitlin E. Sundling et al. ADVANCES IN ANATOMIC PATHOLOGY
- T cell receptor β-chain repertoire analysis of tumor-infiltrating lymphocytes in pancreatic cancer
- (2018) Can Cui et al. CANCER SCIENCE
- PRMT5 Circular RNA Promotes Metastasis of Urothelial Carcinoma of the Bladder through Sponging miR-30c to Induce Epithelial–Mesenchymal Transition
- (2018) Xin Chen et al. CLINICAL CANCER RESEARCH
- Peripheral Blood TCR Repertoire Profiling May Facilitate Patient Stratification for Immunotherapy against Melanoma
- (2018) Sabrina A. Hogan et al. Cancer Immunology Research
- PIWI family emerging as a decisive factor of cell fate: An overview
- (2017) Murugavel Ponnusamy et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Clinical response to PD-1 blockade correlates with a sub-fraction of peripheral central memory CD4+ T cells in patients with malignant melanoma
- (2017) Yoshiko Takeuchi et al. INTERNATIONAL IMMUNOLOGY
- Circular RNAs: emerging cancer biomarkers and targets
- (2017) Yu Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients
- (2017) L. Sorber et al. LUNG CANCER
- SPAG6 and L1TD1 are transcriptionally regulated by DNA methylation in non-small cell lung cancers
- (2017) Corinna Altenberger et al. Molecular Cancer
- Tumour heterogeneity and resistance to cancer therapies
- (2017) Ibiayi Dagogo-Jack et al. Nature Reviews Clinical Oncology
- Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer
- (2017) Mitsuo Tsukamoto et al. ONCOLOGY
- MEG3 is a prognostic factor for CRC and promotes chemosensitivity by enhancing oxaliplatin-induced cell apoptosis
- (2017) Lixia Li et al. ONCOLOGY REPORTS
- Circular RNA hsa_circ_0000745 may serve as a diagnostic marker for gastric cancer
- (2017) Mei Huang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors
- (2017) Viktor A. Adalsteinsson et al. Nature Communications
- Long noncoding RNA XIST is a prognostic factor in colorectal cancer and inhibits 5-fluorouracil-induced cell cytotoxicity through promoting thymidylate synthase expression
- (2017) Yang Xiao et al. Oncotarget
- Expression of MET in circulating tumor cells correlates with expression in tumor tissue from advanced-stage lung cancer patients
- (2017) Marius Ilie et al. Oncotarget
- Stability of Circulating Blood-Based MicroRNAs – Pre-Analytic Methodological Considerations
- (2017) Charlotte Glinge et al. PLoS One
- Circulating tumor cell status monitors the treatment responses in breast cancer patients: a meta-analysis
- (2017) Wen-Ting Yan et al. Scientific Reports
- A Prospective Evaluation of Circulating Tumor Cells and Cell-Free DNA in EGFR-Mutant Non-Small Cell Lung Cancer Patients Treated with Erlotinib on a Phase II Trial
- (2016) M. Yanagita et al. CLINICAL CANCER RESEARCH
- Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors
- (2016) S. Ortiz-Cuaran et al. CLINICAL CANCER RESEARCH
- Clinical Significance of Circulating CD33+CD11b+HLA-DR- Myeloid Cells in Patients with Stage IV Melanoma Treated with Ipilimumab
- (2016) M. Sade-Feldman et al. CLINICAL CANCER RESEARCH
- Association of AR-V7 and Prostate-Specific Antigen RNA Levels in Blood with Efficacy of Abiraterone Acetate and Enzalutamide Treatment in Men with Prostate Cancer
- (2016) Fangfang Qu et al. CLINICAL CANCER RESEARCH
- LncRNA HOTAIR as Prognostic Circulating Marker and Potential Therapeutic Target in Patients with Tumor Diseases
- (2016) Gerardo Botti et al. CURRENT DRUG TARGETS
- The Plasma microRNA miR-1914* and -1915 Suppresses Chemoresistant in Colorectal Cancer Patients by Down-regulating NFIX.
- (2016) J. Hu et al. CURRENT MOLECULAR MEDICINE
- Long noncoding RNA (lincRNA), a new paradigm in gene expression control
- (2016) Emre Deniz et al. FUNCTIONAL & INTEGRATIVE GENOMICS
- PlasmaESR1Mutations and the Treatment of Estrogen Receptor–Positive Advanced Breast Cancer
- (2016) Charlotte Fribbens et al. JOURNAL OF CLINICAL ONCOLOGY
- A novel long non-coding RNA lnc-GNAT1-1 is low expressed in colorectal cancer and acts as a tumor suppressor through regulating RKIP-NF-κB-Snail circuit
- (2016) Chunxiang Ye et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- ctDNA Determination of EGFR Mutation Status in European and Japanese Patients with Advanced NSCLC: The ASSESS Study
- (2016) Martin Reck et al. Journal of Thoracic Oncology
- Droplet digital PCR of circulating tumor cells from colorectal cancer patients can predict KRAS mutations before surgery
- (2016) Jérôme Alexandre Denis et al. Molecular Oncology
- Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
- (2016) Alena Gros et al. NATURE MEDICINE
- A network-biology perspective of microRNA function and dysfunction in cancer
- (2016) Cameron P. Bracken et al. NATURE REVIEWS GENETICS
- Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
- (2016) C. Alix-Panabieres et al. Cancer Discovery
- Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer
- (2016) Qingyun Liu et al. Oncotarget
- Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer
- (2016) Tong Liu et al. Oncotarget
- Examining plasma microRNA markers for colorectal cancer at different stages
- (2016) Yan Sun et al. Oncotarget
- Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer
- (2016) Howard I. Scher et al. JAMA Oncology
- Genomic Alterations in Cell-Free DNA and Enzalutamide Resistance in Castration-Resistant Prostate Cancer
- (2016) Alexander W. Wyatt et al. JAMA Oncology
- Ex Vivo Culture of CTCs: An Emerging Resource to Guide Cancer Therapy
- (2015) S. Maheswaran et al. CANCER RESEARCH
- ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer Patients
- (2015) D. Chu et al. CLINICAL CANCER RESEARCH
- Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer
- (2015) A. A. Azad et al. CLINICAL CANCER RESEARCH
- Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy
- (2015) T. Mok et al. CLINICAL CANCER RESEARCH
- Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes
- (2015) Cyrille J. Cohen et al. JOURNAL OF CLINICAL INVESTIGATION
- Signaling by exosomal microRNAs in cancer
- (2015) Germana Falcone et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- T-cell receptor profiling in cancer
- (2015) Ilan Kirsch et al. Molecular Oncology
- Frequent expression of PD-L1 on circulating breast cancer cells
- (2015) Martine Mazel et al. Molecular Oncology
- Erratum: Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
- (2015) Giulia Siravegna et al. NATURE MEDICINE
- The emerging role of lncRNAs in cancer
- (2015) Maite Huarte NATURE MEDICINE
- RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance
- (2015) D. T. Miyamoto et al. SCIENCE
- Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer
- (2015) Gaia Schiavon et al. Science Translational Medicine
- Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer
- (2015) Muhammed Murtaza et al. Nature Communications
- Circulation long non-coding RNAs act as biomarkers for predicting tumorigenesis and metastasis in hepatocellular carcinoma
- (2015) Junwei Tang et al. Oncotarget
- Association ofEGFRL858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial
- (2015) Niki Karachaliou et al. JAMA Oncology
- Peripheral T cell receptor diversity is associated with clinical outcomes following ipilimumab treatment in metastatic melanoma
- (2015) Michael A. Postow et al. Journal for ImmunoTherapy of Cancer
- Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
- (2014) Nicola Aceto et al. CELL
- Epithelial-Mesenchymal Transitioned Circulating Tumor Cells Capture for Detecting Tumor Progression
- (2014) A. Satelli et al. CLINICAL CANCER RESEARCH
- PIK3CAMutations Are Associated With Lower Rates of Pathologic Complete Response to Anti–Human Epidermal Growth Factor Receptor 2 (HER2) Therapy in Primary HER2-Overexpressing Breast Cancer
- (2014) Sibylle Loibl et al. JOURNAL OF CLINICAL ONCOLOGY
- Gefitinib Treatment in EGFR Mutated Caucasian NSCLC: Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status
- (2014) Jean-Yves Douillard et al. Journal of Thoracic Oncology
- Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients
- (2014) Marta Pestrin et al. Molecular Oncology
- Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA
- (2014) Alain R Thierry et al. NATURE MEDICINE
- Assessment of EGFR Mutations in Circulating Tumor Cell Preparations from NSCLC Patients by Next Generation Sequencing: Toward a Real-Time Liquid Biopsy for Treatment
- (2014) Antonio Marchetti et al. PLoS One
- KRAS Genotypic Changes of Circulating Tumor Cells during Treatment of Patients with Metastatic Colorectal Cancer
- (2014) Aristea Kalikaki et al. PLoS One
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- A high level of circulating HOTAIR is associated with progression and poor prognosis of cervical cancer
- (2014) Jing Li et al. TUMOR BIOLOGY
- Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs
- (2013) Francesco Fabbri et al. CANCER LETTERS
- Plastin3 Is a Novel Marker for Circulating Tumor Cells Undergoing the Epithelial-Mesenchymal Transition and Is Associated with Colorectal Cancer Prognosis
- (2013) T. Yokobori et al. CANCER RESEARCH
- Real-time Liquid Biopsy in Cancer Patients: Fact or Fiction?
- (2013) K. Pantel et al. CANCER RESEARCH
- The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
- (2013) Graeme J.K. Guthrie et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- High-throughput sequencing of T-cell receptors reveals a homogeneous repertoire of tumour-infiltrating lymphocytes in ovarian cancer
- (2013) Ryan O Emerson et al. JOURNAL OF PATHOLOGY
- Circular RNAs are a large class of animal RNAs with regulatory potency
- (2013) Sebastian Memczak et al. NATURE
- Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
- (2013) Muhammed Murtaza et al. NATURE
- Liquid biopsy: monitoring cancer-genetics in the blood
- (2013) Emily Crowley et al. Nature Reviews Clinical Oncology
- Heterogeneity of Estrogen Receptor Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients
- (2013) Anna Babayan et al. PLoS One
- Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
- (2013) M. Yu et al. SCIENCE
- Opportunities and methods for studying alternative splicing in cancer with RNA-Seq
- (2012) Huijuan Feng et al. CANCER LETTERS
- Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood
- (2012) M. J. Higgins et al. CLINICAL CANCER RESEARCH
- Circulating MicroRNAs as Biomarkers of Colorectal Cancer: Results From a Genome-Wide Profiling and Validation Study
- (2012) María Dolores Giráldez et al. Clinical Gastroenterology and Hepatology
- Circulating microRNAs in cancer: origin, function and application
- (2012) Ruimin Ma et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
- (2012) Sandra Misale et al. NATURE
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expression of MicroRNAs in Patients With Pancreatic Cancer and Its Prognostic Significance
- (2012) Ioannis G. Papaconstantinou et al. PANCREAS
- Androgen Receptor Signaling in Circulating Tumor Cells as a Marker of Hormonally Responsive Prostate Cancer
- (2012) David T. Miyamoto et al. Cancer Discovery
- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis
- (2011) Long-gang Wang et al. Cancer Epidemiology
- Circulating Epithelial Cells in Patients with Benign Colon Diseases
- (2011) K. Pantel et al. CLINICAL CHEMISTRY
- Predictive biomarkers: a paradigm shift towards personalized cancer medicine
- (2011) Nicholas B. La Thangue et al. Nature Reviews Clinical Oncology
- HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial
- (2010) Tanja Fehm et al. BREAST CANCER RESEARCH AND TREATMENT
- Long non-coding RNAs: insights into functions
- (2009) Tim R. Mercer et al. NATURE REVIEWS GENETICS
- The impact of microRNAs on protein output
- (2008) Daehyun Baek et al. NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More